The identification of salicylates as normal constituents of serum: a link between diet and health?
Open Access
- 1 July 1998
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 51 (7) , 502-505
- https://doi.org/10.1136/jcp.51.7.502
Abstract
AIM: To examine sera for the presence of salicylic acid and 2,3- and 2,5-dihydroxybenzoic acids (2,3- and 2,5-DHBA), in individuals not taking salicylate drugs. METHODS: Extracts of acidified serum samples were analysed by high performance liquid chromatography with electro-chemical detection. The chromatographic conditions were altered, and the retention times of the unknown compounds compared against authentic salicylic acid, 2,3-DHBA, and 2,5-DHBA. Serum samples (some spiked with salicylic acid) were incubated with salicylate hydroxylase and analyses undertaken. An extract of acidified serum was derivatised using N-methyl-N-trimethylsilyltrifluoroacetamide and the salicylic acid derivative identified by gas chromatography-mass spectrometry. RESULTS: Salicylic acid, 2,3-DHBA, and 2,5-DHBA were identified as being normal constituents of serum. CONCLUSIONS: Salicylic acid, 2,3-DHBA, and 2,5-DHBA possess anti-inflammatory properties. The finding that these compounds are present as normal constituents of serum, possibly arising from diet, raises important questions as to their role in the promotion of health.Keywords
This publication has 23 references indexed in Scilit:
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Determination of Acetylsalicylic Acid and Salicylic Acid in Foods, Using HPLC with Fluorescence DetectionJournal of Agricultural and Food Chemistry, 1996
- Aspirin as Prophylaxis against Colorectal CancerNew England Journal of Medicine, 1995
- Take two glasses of wine and see me in the morningThe Lancet, 1994
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Is aspirin a prodrug for antioxidant and cytokine-modulating oxymetabolitesInflammation Research, 1993
- Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity.Proceedings of the National Academy of Sciences, 1987
- Some characteristics of the prostaglandin synthesizing system in rabbit kidney microsomesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1975
- SALICYLATE METABOLISM IN MANAnnals of the New York Academy of Sciences, 1971